Rabeloc 20/Rabeloc IV Indications/Uses

Rabeloc Sodium (Rabeloc I.V.) 20 mg Lyophilized Powder for I.V. Injection is indicated for the treatment of: Sequential-therapy [Step-Up] therapy from oral Rabeloc, e.g. a patient previously on Oral Rabeprazole Sodium who is temporarily unable to take oral Rx for any reason, e.g. during a surgical procedure.
Active duodenal ulcer with bleeding or severe erosions.
Active gastric ulcer with bleeding or severe erosions.
Severe erosive or ulcerative gastroesophageal reflux disease (GORD/GERD) or Non-erosive Reflux Disease [NERD] where patient is unable to take oral PPIs.
Prevention of Acid-Aspiration during Surgery.
Stress-induced mucosal injury in critical care, e.g. head-injury burns, MI, etc.
Rabeloc Sodium (Rabeloc 10) 10 mg Enteric-Coated Tablet/Rabeloc Sodium (Rabeloc 20) 20 mg Enteric-Coated Tablet is indicated for the treatment of: Sequential-therapy [Step-down] therapy from the intravenous Rabeloc Sodium.
Active duodenal ulcer.
Active gastric ulcer.
Symptomatic erosive or ulcerative gastroesophageal reflux disease (GORD/GERD) or Non-erosive Reflux Disease [NERD].
H. Pylori-positive duodenal ulcers, as part of the eradication programme with appropriate antibiotics, e.g. Amoxycillin and Clarithromycin.
Maintenance treatment of healed erosive or ulcerative GORD.